Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Placental tissue shows promise for stubborn wounds

NCT ID NCT07215741

Disease control Sponsor: StimLabs Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study looks at how well a product made from donated placental tissue helps close hard-to-heal wounds, such as diabetic foot ulcers and venous leg ulcers. Researchers will review medical records of 50 people who received this treatment to see how many wounds fully closed within 12 weeks. The goal is to understand if this real-world use leads to better healing outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
human placental membrane tissue (Relese)
What this could lead to
If successful, this could provide a better treatment option for people with hard-to-heal wounds, potentially leading to faster and more complete wound closure.
What could go wrong
This is a small, retrospective study without a control group, so results may not prove the treatment is better than standard care. Outcomes depend on real-world factors that are not tightly controlled.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

23 people

The number who actually took part.

Started

Sep 2025

Finished

Nov 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Consecutive subjects receiving Relese in a real-world setting

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Consecutive diabetic subjects that received a Relese product application during treatment between May 2023 and April 2025. Exclusion Criteria: * Subjects not receiving an initial Relese application during treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic wounds are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic wounds Diabetic ulcers

Contacts and locations

Locations

  • Cypress Wound Care

    Oklahoma City, Oklahoma, 73103, United States

  • Premier Foot & Ankle

    Denison, Texas, 75020, United States

  • Premier Foot & Ankle

    Frisco, Texas, 75033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.